On Monday, Aldeyra Therapeutics Inc (ALDX) stock saw a modest uptick, ending the day at $4.7 which represents a slight increase of $0.49 or 11.64% from the prior close of $4.21. The stock opened at $4 ...
The FDA accepts Aldeyra's resubmitted NDA for topical ocular reproxalap to treat the signs and symptoms of dry eye disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback